Pathogenesis, diagnosis, and management of severe pelvic inflammatory disease and tuboovarian abscess

Clin Obstet Gynecol. 2012 Dec;55(4):893-903. doi: 10.1097/GRF.0b013e3182714681.

Abstract

Severe pelvic inflammatory disease and tuboovarian abscesses (TOAs) are common pelvic infections requiring inpatient admission. There are few large randomized trials guiding appropriate clinical management of TOA, including antibiotic selection and timing of surgical management and drainage. The pathogenesis, diagnosis, and management of severe pelvic inflammatory disease and TOA are summarized and reviewed from the most current literature.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Abdominal Abscess / diagnosis*
  • Abdominal Abscess / microbiology
  • Abdominal Abscess / therapy*
  • Anti-Bacterial Agents / therapeutic use
  • Drainage
  • Fallopian Tube Diseases / diagnosis*
  • Fallopian Tube Diseases / microbiology
  • Fallopian Tube Diseases / therapy
  • Female
  • Humans
  • Ovarian Diseases / diagnosis*
  • Ovarian Diseases / microbiology
  • Ovarian Diseases / therapy
  • Pelvic Inflammatory Disease / diagnosis*
  • Pelvic Inflammatory Disease / epidemiology
  • Pelvic Inflammatory Disease / microbiology
  • Pelvic Inflammatory Disease / therapy*

Substances

  • Anti-Bacterial Agents